Liquidia Corp
LQDA
81 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | May 28 8:30 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 6,428 | $62.18 | $399.7K | 1,041,667(I) | View → |
| May 21, 2026 | May 26 10:17 PM | Raman SinghDirector | Sale | 29,494 | $60.13 | $1.8M | 38,755(D) | View → |
| May 26, 2026 | May 26 10:16 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $60.38 | $1.5M | 1,048,095(I) | View → |
| May 22, 2026 | May 26 10:16 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $61.52 | $1.5M | 1,073,095(I) | View → |
| May 21, 2026 | May 26 10:16 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $61.13 | $1.5M | 1,098,095(I) | View → |
| May 21, 2026 | May 21 9:12 PM | RAMANDEEP SINGH | Proposed Sale | 29,494 | $60.13 | $1.8M | — | View → |
| May 19, 2026 | May 21 12:51 AM | Caligan Partners LPDirector, 10% Owner, Other | Purchase | 5,300 | $59.98 | $317.9K | 8,138,951(I) | View → |
| May 19, 2026 | May 21 12:51 AM | Caligan Partners LPDirector, 10% Owner, Other | Sale | 5,300 | $59.98 | $317.9K | 8,133,651(I) | View → |
| May 20, 2026 | May 20 10:55 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $61.30 | $1.5M | 1,123,095(I) | View → |
| May 19, 2026 | May 20 10:55 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $58.65 | $1.5M | 1,148,095(I) | View → |
| May 18, 2026 | May 20 10:55 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $56.77 | $1.4M | 1,173,095(I) | View → |
| May 20, 2026 | May 20 8:37 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 106,428 | $59.98 | $6.4M | — | View → |
| May 15, 2026 | May 15 10:59 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $57.04 | $1.4M | 1,198,095(I) | View → |
| May 14, 2026 | May 15 10:59 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $58.62 | $1.5M | 1,223,095(I) | View → |
| May 13, 2026 | May 15 10:59 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $56.29 | $1.4M | 1,248,095(I) | View → |
| May 14, 2026 | May 14 8:26 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 100,000 | $57.59 | $5.8M | — | View → |
| May 11, 2026 | May 13 8:30 PM | Stephen M BlochDirector | Sale | 318,893 | $50.23 | $16.0M | 1,870,042(I) | View → |
| May 12, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $54.04 | $1.4M | 1,273,095(I) | View → |
| May 11, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $41.50 | $1.0M | 1,298,095(I) | View → |
| May 8, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $42.14 | $1.1M | 1,323,095(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | Mar 25 8:30 PM | Scott MoomawChief Commercial Officer | Option Exercise | 17,000 | $3.40 | 8,300(D) | View → |
| Mar 13, 2026 | Mar 17 8:30 PM | Raman SinghDirector | Option Exercise | 20,000 | $4.86 | 0(D) | View → |
| Mar 9, 2026 | Mar 11 8:30 PM | Scott MoomawChief Commercial Officer | Option Exercise | 80,000 | $3.40 | 25,300(D) | View → |
| Feb 27, 2026 | Mar 3 9:34 PM | Russell SchundlerGeneral Counsel | Option Exercise | 2,344 | — | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:33 PM | Scott MoomawChief Commercial Officer | Option Exercise | 1,875 | — | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:31 PM | Michael KasetaCFO and COO | Option Exercise | 2,344 | — | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:30 PM | Jason AdairChief Business Officer | Option Exercise | 1,562 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 21 11:28 PM | Jason AdairChief Business Officer | Grant/Award | 41,525 | — | 41,525(D) | View → |
| Jan 16, 2026 | Jan 21 11:27 PM | Dana BoyleChief Accounting Officer | Grant/Award | 35,592 | — | 35,592(D) | View → |
| Jan 16, 2026 | Jan 21 11:24 PM | Roger JeffsDirector, Chief Executive Officer | Grant/Award | 173,016 | — | 173,016(D) | View → |
| Jan 16, 2026 | Jan 21 11:23 PM | Michael KasetaCFO and COO | Grant/Award | 88,980 | — | 88,980(D) | View → |
| Jan 16, 2026 | Jan 21 11:20 PM | Sarah KreppChief Human Resource Officer | Grant/Award | 35,592 | — | 35,592(D) | View → |
| Jan 16, 2026 | Jan 21 11:18 PM | Scott MoomawChief Commercial Officer | Grant/Award | 49,433 | — | 49,433(D) | View → |
| Jan 16, 2026 | Jan 21 11:16 PM | Rajeev SaggarChief Medical Officer | Grant/Award | 49,433 | — | 49,433(D) | View → |
| Jan 16, 2026 | Jan 21 11:16 PM | Russell SchundlerGeneral Counsel | Grant/Award | 49,433 | — | 49,433(D) | View → |
← Previous
Page 2 of 2